Diabetes Clinical Trials in Maryland

Showing 521-540 of 574 trials

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

NCT01415115

The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.

Type 1 DiabetesType 2 Diabetes

VeraLight, Inc.250 participantsStarted Mar 2007

Hyattsville, Maryland, United States

TERMINATEDPhase 312 miles

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

NCT00226330

This is a parallel-group, multi-center, long-term extension study from the GALLANT 6 study to monitor the safety and tolerability of oral tesaglitazar compared with pioglitazone in patients with type 2 diabetes for up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.

Diabetes Mellitus, Type 2

AstraZeneca1,100 participantsStarted Mar 2005

Birmingham, Alabama, United States • Columbiana, Alabama, United States • Mobile, Alabama, United States +168 more locations

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

A Study for Patients With Type 2 Diabetes Mellitus

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms

GALLANT 6 Tesaglitazar vs. Pioglitazone

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

A Study in Patients With Type 2 Diabetes

A Study for Type 2 Diabetic Patients

DPBRN Blood Sugar Testing in Dental Patients

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Other Conditions in Maryland